MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.

PLoS One · 2015 · PMC4659591 · PMID 26606261

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

did not reach statistical significancep = 0.063so close (0.05 < p ≤ 0.1)

Expression of the miR- and mt-p53- target and cell cycle regulator CDK1 was increased in MIA-PaCa-2-GR cells but did not reach statistical significance ( p = 0.063).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.